SEC Form 4 · accession 0001104659-18-046530
Rubius Therapeutics, Inc. · RUBY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Pomerantz
Director
Period of report
Jul 20, 2018
Accepted (ET)
Jul 23, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001709401
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2018 | P | 100 | $23.00 | A | 100 | D |
Table II — derivative securities
No Table II lines on this filing.